Azam Roohi | Nutrition and Immunology Award | Best Researcher Award

Posted on by ScienceFather

Dr. Azam Roohi | Nutrition and Immunology Award | Best Researcher Award

Dr. Azam Roohi, Tehran University of Medical Sciences, Iran

Dr. Azam Roohi is an esteemed immunologist at Tehran University of Medical Sciences. With a Ph.D. in Molecular Medicine and a career spanning over two decades, Dr. Roohi’s research focuses on immune system regulation, particularly through mTOR signaling and cytokine assays. She has authored numerous publications and taught advanced immunology courses. Dr. Roohi’s expertise includes monoclonal antibody production and flow cytometry. Her work has significant implications for diabetes and autoimmune diseases. πŸŒΏπŸ”¬πŸ“š She is known for her dedication to scientific advancement and education in the field of immunology. πŸ“–πŸ‘©β€πŸ”¬πŸŒ

Publication profile

Orcid

Education

Dr. Azam Roohi holds a Ph.D. in Molecular Medicine from Tehran University of Medical Sciences, focusing on the impact of high glucose levels and oxidative stress on TGF beta secretion through the m-TOR signaling pathway in placental mesenchymal stem cells. With an academic journey spanning from Microbiology to Virology and finally Molecular Medicine, Dr. Roohi has amassed extensive expertise in molecular techniques such as PCR, qPCR, and protein analysis methods including SDS-PAGE and Western blotting.

Professional Experience πŸ’Ό

Dr. Roohi’s career is characterized by significant contributions in research and academia. Notable roles include work at Tehran University of Medical Sciences’ Endocrinology and Metabolism Research Institute and the School of Public Health’s Department of Immunology. Her research spans from cytokine assays to monoclonal antibody production, with a focus on immune system regulation and immunometabolism.

Teaching

Dr. Roohi is committed to education, teaching advanced topics in immunology at Tehran University of Medical Sciences. Her instructional roles include courses on mTOR signaling and immune system regulation, highlighting her role in shaping the next generation of immunologists. Dr. Roohi’s dedication to both research and education underscores her multidimensional impact in the field of medical sciences.

Research Focus

Azam Roohi’s research primarily focuses on immunology and molecular biology, with a specific interest in autoimmune diseases, cancer immunotherapy, and vaccine development. Her work spans various aspects of immune system modulation, including the role of gamma delta T cells in cancer, therapeutic strategies involving cytokines like interferons, and the impact of metabolic conditions on cellular responses. Roohi’s contributions are characterized by a multidisciplinary approach that integrates cellular biology with clinical implications, aiming to elucidate novel targets for disease intervention and treatment. Her research not only explores fundamental immunological mechanisms but also explores practical applications in clinical settings, fostering advancements in therapeutic strategies. 🧬

 

Publication Top Notes

Vitamin D supplementation and calcium: Many-faced gods or nobody in fighting against Corona Virus Disease 2019

Controversial role of gamma delta T cells in pancreatic cancer

May interferon. be a novel therapeutic approach against COVID-19?

High Glucose Affects the Cytotoxic Potential of Rapamycin, Metformin and Hydrogen Peroxide in Cultured Human Mesenchymal Stem Cells

Healthy Adult LDL-C Bears Reverse Association with Serum IL-17A Levels

ABCA1 genetic polymorphisms and type 2 diabetes mellitus and its complications

Effect of metformin and celecoxib on cytotoxicity and release of GDF-15 from human mesenchymal stem cells in high glucose condition

Recent advances in targeting mTOR signaling pathway using small molecule inhibitors

Analysis of Knowledge, Attitudes, and Prevalence of Hepatitis B and C Seromarkers Among Barbers in Tehran

Serum IL-17, IL-23, and TGF-beta Levels in Type 1 and Type 2 Diabetic Patients and Age-Matched Healthy Controls

 

Peng Xiao | Macrophage Biology | Best Researcher Award

Posted on by ScienceFather

Assoc Prof Dr. Peng Xiao | Macrophage Biology | Best Researcher Award

Assoc Prof Dr. Peng Xiao, Zhejiang University, China

Dr. Peng Xiao, Assoc. Prof., is a distinguished immunologist specializing in Macrophage Biology. Holding an MD from Zhejiang University, he completed postdoctoral research at Harvard University before joining Zhejiang University as Assistant Professor, later promoted to Associate Professor. Dr. Xiao is a member of prestigious organizations including The American Association of Immunologists, Society for Mucosal Immunology, and Chinese Society for Immunology. He serves on the Editorial Board of the Journal of Leukocyte Biology. Passionate about unraveling mysteries of the immune system 🦠, Dr. Xiao’s research significantly contributes to understanding macrophage function and immunological processes.

Publication Profile:

Scopus

Orcid

Education:

Dr. Peng Xiao’s academic journey reflects a commitment to advancing knowledge in immunology. Beginning with his MD from Zhejiang University’s Institute of Immunology from 2011 to 2015 πŸŽ“, he laid a solid foundation in medical science. Eager to delve deeper into research, he pursued a postdoctoral position at Harvard University’s Medicine School from 2019 to 2021 πŸ₯. During this time, he honed his expertise in macrophage biology, a field he’s passionate about.Returning to Zhejiang University in 2015, Dr. Xiao transitioned to the role of Assistant Professor, where he actively contributed to both teaching and research. Recognized for his exceptional dedication and contributions to the field, he was promoted to Associate Professor in 2019, reaffirming his position as a respected figure in academia πŸ“š.

Employment:

Dr. Peng Xiao’s professional journey spans across two renowned institutions, showcasing his dedication to advancing research in immunology. At Zhejiang University in Hangzhou, China 🏫, Dr. Xiao has been deeply engaged in academia, contributing significantly as an Associate Professor. His tenure at this esteemed university underscores his commitment to education and research, where he actively participates in shaping the next generation of scholars and delving into the complexities of immunological science.In parallel, Dr. Xiao’s pursuit of excellence led him to Harvard Medical School in Boston, Massachusetts πŸ‡ΊπŸ‡Έ, where he undertook a prestigious postdoctoral position. Immersed in the vibrant academic environment of one of the world’s leading medical institutions, Dr. Xiao furthered his expertise in immunology, particularly in the field of macrophage biology. His time at Harvard Medical School not only enriched his knowledge but also facilitated collaborations and networking opportunities with leading experts in the field.Through his employment at both Zhejiang University and Harvard Medical School, Dr. Xiao demonstrates his unwavering dedication to advancing scientific knowledge and making meaningful contributions to the field of immunology. His experiences at these distinguished institutions have undoubtedly shaped his trajectory as a respected researcher and educator.

Research Focus:

Dr. Peng Xiao’s research focuses on immunological mechanisms and their implications in various diseases, particularly emphasizing macrophage biology. His work spans understanding the role of macrophages in gut homeostasis, melanoma progression, and pulmonary fibrosis, among other conditions. Through his investigations, Dr. Xiao has elucidated pathways involving cytokines like TNF-Ξ± and IL-10, shedding light on potential therapeutic targets for inflammatory disorders and cancer. With a keen interest in unraveling the complexities of the immune system 🧬, his contributions pave the way for novel interventions and treatments to alleviate disease burden and improve patient outcomes.

Publication Top Notes:

  1. Mannose metabolism normalizes gut homeostasis by blocking the TNF-Ξ±-mediated proinflammatory circuit – Published in 2022 πŸ“š
  2. PGAM5: A necroptosis gene associated with poor tumor prognosis that promotes cutaneous melanoma progression – Published in 2022 🩺
  3. Macrophage orchestration of epithelial and stromal cell homeostasis in the intestine – Published in 2022 🦠
  4. Myeloid Fbxw7 Prevents Pulmonary Fibrosis by Suppressing TGF-Ξ² Production – Published in 2022 🫁
  5. Induction of co-inhibitory molecule CTLA-4 by human papillomavirus E7 protein through downregulation of histone methyltransferase JHDM1B expression – Published in 2019 🦠
  6. Phosphatase Shp2 exacerbates intestinal inflammation by disrupting macrophage responsiveness to interleukin-10 – Published in 2019 🧫
  7. USP16-mediated deubiquitination of calcineurin A controls peripheral T cell maintenance – Published in 2019 πŸ”¬
  8. Myeloid-restricted ablation of Shp2 restrains melanoma growth by amplifying the reciprocal promotion of CXCL9 and IFN-Ξ³ production in tumor microenvironment – Published in 2018 🦠
  9. Cellular Phenotypic Analysis of Macrophage Activation Unveils Kinetic Responses of Agents Targeting Phosphorylation – Published in 2017 🧬
  10. E3 ligase FBXW7 is critical for RIG-I stabilization during antiviral responses – Published in 2017 πŸ¦